Simon N Rogers1, Derek Lowe. 1. Regional Maxillofacial Unit, Aintree University Hospitals NHS Foundation Trust, Aintree, Liverpool L9 7AL, England. snrogers@doctors.org.uk
Abstract
OBJECTIVE: To investigate the potential of the University of Washington Quality of Life Questionnaire (UW-QOL) in routine clinics as a quick screening tool for possible dysfunction in patients after treatment of head and neck cancer. DESIGN: Retrospective analysis. SETTING: Regional Maxillofacial Unit, Aintree University Hospitals National Health Service Foundation Trust Liverpool, a National Health Service teaching hospital. PATIENTS: Consecutive disease-free patients with oral or oropharyngeal squamous cell carcinoma, who had undergone primary surgery with or without adjuvant radiotherapy, for whom UW-QOL version 4 data from 2000 to May 2006 were available in our research database; and consecutive patients from previous studies (4 postal surveys of disease-free patients with oral or oropharyngeal squamous cell carcinoma, 1 clinic-based study that targeted speech and swallowing in patients with oropharyngeal disease, 1 that evaluated shoulder function in patients with various diagnoses, and 1 that recruited patients without cancer attending a general dental practice). MAIN OUTCOME MEASURES: Cutoff strategies for further evaluation/intervention derived from studies using the UW-QOL in parallel with 13 other established questionnaires. Effects of preferred cutoffs on trigger variation were assessed with the use of all available UW-QOL version 4 data (615 patients). RESULTS: Trigger rates for further intervention fell between 9% (recreation and speech) and 16% (swallowing). Eighty-one percent of patients with free-flap surgery and adjuvant therapy for T3 or T4 tumors met the trigger criteria at around 2 years, with 42% meeting the trigger on 3 or more domains. CONCLUSION: The fourth version of the UW-QOL is suitable for routine screening in clinical practice.
OBJECTIVE: To investigate the potential of the University of Washington Quality of Life Questionnaire (UW-QOL) in routine clinics as a quick screening tool for possible dysfunction in patients after treatment of head and neck cancer. DESIGN: Retrospective analysis. SETTING: Regional Maxillofacial Unit, Aintree University Hospitals National Health Service Foundation Trust Liverpool, a National Health Service teaching hospital. PATIENTS: Consecutive disease-free patients with oral or oropharyngeal squamous cell carcinoma, who had undergone primary surgery with or without adjuvant radiotherapy, for whom UW-QOL version 4 data from 2000 to May 2006 were available in our research database; and consecutive patients from previous studies (4 postal surveys of disease-free patients with oral or oropharyngeal squamous cell carcinoma, 1 clinic-based study that targeted speech and swallowing in patients with oropharyngeal disease, 1 that evaluated shoulder function in patients with various diagnoses, and 1 that recruited patients without cancer attending a general dental practice). MAIN OUTCOME MEASURES: Cutoff strategies for further evaluation/intervention derived from studies using the UW-QOL in parallel with 13 other established questionnaires. Effects of preferred cutoffs on trigger variation were assessed with the use of all available UW-QOL version 4 data (615 patients). RESULTS: Trigger rates for further intervention fell between 9% (recreation and speech) and 16% (swallowing). Eighty-one percent of patients with free-flap surgery and adjuvant therapy for T3 or T4 tumors met the trigger criteria at around 2 years, with 42% meeting the trigger on 3 or more domains. CONCLUSION: The fourth version of the UW-QOL is suitable for routine screening in clinical practice.
Authors: A Kanatas; N Ghazali; D Lowe; M Udberg; J Heseltine; E O'Mahony; S N Rogers Journal: Eur Arch Otorhinolaryngol Date: 2012-06-29 Impact factor: 2.503
Authors: Stephanie L Pugh; Gwen Wyatt; Raimond K W Wong; Stephen M Sagar; Bevan Yueh; Anurag K Singh; Min Yao; Phuc Felix Nguyen-Tan; Sue S Yom; Francis S Cardinale; Khalil Sultanem; D Ian Hodson; Greg A Krempl; Ariel Chavez; Alexander M Yeh; Deborah W Bruner Journal: J Pain Symptom Manage Date: 2016-11-27 Impact factor: 3.612
Authors: S N Rogers; E S Hogg; W K A Cheung; L K L Lai; P Jassal; D Lowe; A Kanatas Journal: Eur Arch Otorhinolaryngol Date: 2014-07-22 Impact factor: 2.503
Authors: Naseem Ghazali; Brenda Roe; Derek Lowe; Sank Tandon; Terry Jones; James Brown; Richard Shaw; Janet Risk; Simon N Rogers Journal: Eur Arch Otorhinolaryngol Date: 2017-02-06 Impact factor: 2.503
Authors: S N Rogers; R S Pinto; J Lancaster; F Bekiroglu; D Lowe; S Tandon; T M Jones Journal: Eur Arch Otorhinolaryngol Date: 2016-04-18 Impact factor: 2.503